In-vitro platelet hyperaggregation and hypersecretion associated with the use of fish oil in healthy children

Bulent Alioglu1, Tugba Zengin, Nermin Dindar

  • 1Department of Pediatric Hematology, Ankara Training and Research Hospital; Director of Blood Bank, Therapeutic Apheresis and Hematology Laboratories , Ankara , Turkey.

Insights

Fish oil supplementation in children may increase platelet aggregation and secretion, potentially affecting its use as an antithrombotic agent. Further research is needed to understand these in-vitro effects.

Area of Science:

  • Pediatric Hematology
  • Nutritional Science
  • Pharmacology

Background:

  • Fish oil contains eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA).
  • Platelet function is crucial for hemostasis and thrombosis.
  • The effects of fish oil on pediatric platelet function require investigation.

Purpose of the Study:

  • To evaluate the in vitro effects of fish oil supplementation on platelet function tests in children.
  • To assess changes in platelet aggregation and secretion after fish oil intake.

Main Methods:

  • A study involving 62 children aged 2-12 years.
  • Comparison between a control group and a fish oil-supplemented group.
  • Platelet function tests (aggregation and secretion) were performed at baseline, 4 weeks, and 8 weeks.

Main Results:

  • Fish oil supplementation significantly increased platelet aggregation induced by ADP after 8 weeks.
  • Increased platelet secretion was observed with collagen, thrombin (standard and high dose), and ADP (standard dose) at 4 and 8 weeks.
  • In vitro hyperaggregation and increased platelet secretion were noted in the fish oil group.

Conclusions:

  • Fish oil, particularly EPA and DHA, can induce in vitro hyperaggregation and increase platelet secretion in children.
  • Caution is advised when using fish oil supplementation in pediatric populations, especially for antithrombotic purposes.
  • Further studies are warranted to elucidate the clinical implications of these in vitro findings.
Abstract

Related Concept Videos

Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...